Difference between revisions of "Cisplatin (Platinol)"
Jump to navigation
Jump to search
m |
|||
| Line 19: | Line 19: | ||
**patient drug information | **patient drug information | ||
| − | [http://hemonc.org/index.php?title=Special:WhatLinksHere/ | + | [http://hemonc.org/index.php?title=Special:WhatLinksHere/Cisplatin_(Platinol) List of regimens containing cisplatin] |
==References== | ==References== | ||
[http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018057s080lbl.pdf Cisplatin package insert (8/2011)] | [http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018057s080lbl.pdf Cisplatin package insert (8/2011)] | ||
Revision as of 06:04, 12 November 2011
Template to be used for chemotherapies:
Mechanism
- Platinum analog, alkylating-like
- metabolism
- Excretion: renal ~90%, bile 10%
- CYP450: unknown
Dosing
- Renal dose adjustments
- Hepatic dose adjustments
Routes of administration: IV
- Vesicant?
- Antidote?
Side effects
- informed consent info
- patient drug information
List of regimens containing cisplatin